Nanwei Xu
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallenge.
Journal: Journal for immunotherapy of cancer
Published: May 11, 2026
First-line systemic therapy in patients with metastatic or locally advanced urothelial carcinoma: a systematic review and network meta-analysis of randomized controlled trials.
Journal: Therapeutic advances in medical oncology
Published: February 21, 2025
Predicting pathogenic DNA damage repair gene mutations in prostate cancer patients: a multi-center magnetic resonance imaging radiomics study.
Journal: Quantitative imaging in medicine and surgery
Published: December 01, 2024
Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/ml.
Journal: World journal of urology
Published: May 10, 2024
Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis.
Journal: Journal of advanced research
Published: May 03, 2024
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.
Journal: Nature communications
Published: March 06, 2024
Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis.
Journal: International journal of surgery (London, England)
Published: October 27, 2023
Molecular complexity of intraductal carcinoma of the prostate.
Journal: Cancer medicine
Published: June 27, 2023
Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.
Journal: Annals of translational medicine
Published: March 22, 2023
Last Updated: 09/26/2026